Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.

Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.

Habermehl D, Kammerer B, Handrick R, Eldh T, Gruber C, Cordes N, Daniel PT, Plasswilm L, Bamberg M, Belka C, Jendrossek V.

BMC Cancer. 2006 Jan 17;6:14.

3.

Ukrain (NSC-631570) in experimental and clinical studies: a review.

Jagiello-Wójtowicz E, Kleinrok Z, Urbanska EM.

Drugs Exp Clin Res. 1998;24(5-6):213-9. Review.

PMID:
10190077
4.
5.

Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer.

Susak YM, Zemskov VS, Yaremchuk OY, Kravchenco OB, Yatsyk IM, Korsh OB.

Drugs Exp Clin Res. 1996;22(3-5):115-22.

PMID:
8899313
6.

In-vitro toxicity of Ukrain against human Ewing tumor cell lines.

Lanvers-Kaminsky C, Nolting DM, Köster J, Schröder A, Sandkötter J, Boos J.

Anticancer Drugs. 2006 Oct;17(9):1025-30.

PMID:
17001175
7.

Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.

Panzer A, Joubert AM, Eloff JN, Albrecht CF, Erasmus E, Seegers JC.

Cancer Lett. 2000 Nov 28;160(2):237-41.

PMID:
11053654
8.

In vitro and in vivo investigations on the antitumour activity of Chelidonium majus.

Capistrano I R, Wouters A, Lardon F, Gravekamp C, Apers S, Pieters L.

Phytomedicine. 2015 Dec 15;22(14):1279-87. doi: 10.1016/j.phymed.2015.10.013. Epub 2015 Nov 10.

PMID:
26626193
9.

Ukrain: a novel antitumor drug.

Uglyanitsa KN, Nefyodov LI, Doroshenko YM, Nowicky JW, Volchek IV, Brzosko WJ, Hodysh YJ.

Drugs Exp Clin Res. 2000;26(5-6):341-56. Review.

PMID:
11345050
10.

Chelidonium majus L. (Ukrain) in the treatment of cancer patients.

Lohninger A, Hamler F.

Drugs Exp Clin Res. 1992;18 Suppl:73-7.

PMID:
1305049
11.

Ukrain therapy of stage T1N0M0 bladder cancer patients.

Uglianitsa KN, Nechiporenko NA, Nefyodov LI, Brzosko WJ.

Drugs Exp Clin Res. 1998;24(5-6):227-30.

PMID:
10190079
12.

Homotoxicology--a review of randomised clinical trials.

Ernst E, Schmidt K.

Eur J Clin Pharmacol. 2004 Jul;60(5):299-306. Epub 2004 Jun 9. Review.

PMID:
15197516
13.

Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI.

Nefyodov LI, Uglyanica KN, Smirnov VY, Doroshenko YM, Fomin KA, Nowicky JW, Brzosko WJ.

Drugs Exp Clin Res. 1996;22(3-5):159-61.

PMID:
8899321
14.

Ukrain both as an anti cancer and immunoregulatory agent.

Nowicky JW, Manolakis G, Meijer D, Vatanasapt V, Brzosko WJ.

Drugs Exp Clin Res. 1992;18 Suppl:51-4.

PMID:
1305045
15.

Influence of Ukrain on patients with surgically treated breast cancer (introductory remarks).

Uglyanica KN, Fomin KA, Nefyodov LI, Nowicky JW, Brzosko WJ, Jankowski A.

Drugs Exp Clin Res. 1996;22(3-5):123-5.

PMID:
8899314
16.

Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies.

Uglianitsa KN, Nefyodov LI, Brzosko W.

Drugs Exp Clin Res. 1998;24(5-6):231-9.

PMID:
10190080
17.

Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters.

Uglyanica KN, Fomin KA, Nefyodov LI, Nowicky JW, Brzosko WJ, Jankowski A.

Drugs Exp Clin Res. 1996;22(3-5):135-8.

PMID:
8899316
18.

Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.

Uglyanitsa KN, Nefyodov LI, Doroshenko YM, Brzosko WJ.

Drugs Exp Clin Res. 2000;26(5-6):201-21.

PMID:
11345028
19.

Amino acids and their derivatives in blood plasma of patients with breast cancer treated with Ukrain. Part V.

Nefyodov LI, Uglyanica KN, Smirnov VY, Doroshenko YM, Fomin KA, Nowicky JW, Brzosko WJ.

Drugs Exp Clin Res. 1996;22(3-5):155-7.

PMID:
8899320
20.

Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.

Nowicky JW, Staniszewski A, Zbroja-Sontag W, Slesak B, Nowicky W, Hiesmayr W.

Drugs Exp Clin Res. 1991;17(2):139-43.

PMID:
1713821

Supplemental Content

Support Center